PT-141 (Bremelanotide): A Research Peptide Overview
Share
PT-141 (Bremelanotide) is a melanocortin research peptide studied for its receptor-pathway activity. This overview covers what it is, the pathways it's associated with, and how to source research-grade material.
What is PT-141?
PT-141, also known as Bremelanotide, is a synthetic peptide and a metabolite of the earlier compound Melanotan II. It is studied as an agonist of melanocortin receptors.
Research pathways
- Melanocortin-receptor (MC3R / MC4R) signaling research.
- Central-nervous-system signaling research models.
- Comparative melanocortin-pathway studies.
These describe areas of laboratory investigation; PT-141 is a research compound and not a therapeutic product.
Formats & doses
PT-141 is supplied in lyophilized and pre-reconstituted activated forms: PT-141 (10mg). It sits within the Hormone & Reproductive research collection alongside other receptor-pathway peptides.
Handling, reconstitution & purity
Reconstitute lyophilized PT-141 with bacteriostatic water per our reconstitution guide. All material is ≥98% HPLC-verified, documented on the Quality & COA page.
Manufacturing & Quality
Alpha Biologix manufactures PT-141 (Bremelanotide) under pharmaceutical-grade manufacturing standards. Every batch is verified to ≥98% HPLC purity, tested by independent third-party laboratories, and accompanied by a Certificate of Analysis (COA) available per batch.
All products and information are provided for laboratory and research use only. Not for human or veterinary use, diagnostic, or therapeutic application. No medical claims are made.